SCHEDULE: GRI Bio, Inc. Ownership Update

Reporting Persons disclose beneficial ownership of 90,475 shares of GRI Bio, Inc. common stock, representing 5.9% of the class.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership reporting for GRI Bio, Inc.
• The reporting persons include Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.
• As of March 31, 2026, the reporting persons collectively beneficially own 90,475 shares of GRI Bio, Inc. common stock.
• This ownership represents approximately 5.9% of the total outstanding common stock.
• The reported shares are primarily issuable upon the exercise of a warrant held by Intracoastal Capital LLC.
• Certain other warrants held by Intracoastal Capital LLC are excluded from the beneficial ownership calculation due to blocker provisions that limit ownership to 4.99%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership without new strategic information or financial performance data.

Positives

• The reporting persons have disclosed their beneficial ownership, providing transparency to the market.
• The disclosed ownership stake of 5.9% indicates a significant interest in GRI Bio, Inc.

Negatives

• The exclusion of shares from other warrants due to blocker provisions suggests potential limitations on future increases in ownership or strategic flexibility for the reporting persons.

Risks

• The blocker provisions in Intracoastal Warrant 2 and Intracoastal Warrant 3 limit the ability of the reporting persons to acquire more than 4.99% of the common stock, potentially impacting their influence or investment strategy.
• Future changes in the outstanding share count of GRI Bio, Inc. could alter the percentage ownership reported by the filing persons.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of current beneficial ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and significant shareholders, providing transparency regarding ownership stakes. This filing indicates a notable position in GRI Bio, Inc. by the reporting persons.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership stakes can influence investor confidence and market perception.
• Management: Awareness of substantial beneficial ownership can inform strategic decisions and shareholder engagement efforts.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership in GRI Bio, Inc. and may adjust their holdings based on market conditions and investment strategies.
• Further filings may be required if ownership levels change significantly or if the nature of their holdings changes.

Key Dates

Keywords

Schedule 13G, GRI Bio, Inc., Beneficial Ownership, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Common Stock, Warrant Exercise, SEC Filing, Ownership Stake